The justices, two years after ending the recognition of a constitutional right to abortion, ruled 9-0 to overturn a lower court’s decision to roll back Food and Drug Administration steps in 2016 and 2021 that eased how the drug, called mifepristone, is prescribed and distributed.
The pill, given FDA regulatory approval in 2000, is used in more than 60% of U.S. abortions.
The court ruled that the plaintiffs behind the lawsuit challenging mifepristone lacked the necessary legal standing to pursue the case, which required that they show they have been harmed in a way that can be traced to the FDA.
Join the conversation as a VIP Member